Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SDC3 |
| Upstream (Parents) |
|---|
| (<<) FZD4 → SDC3 |
| (<<) ARHGEF6 → SDC3 |
| (<<) MCOLN1 → SDC3 |
| (<<) C19orf66 → SDC3 |
| (<<) EVL → SDC3 |
| Downstream (Children) |
|---|
| SDC3 → ZNF10 (>>) |
| SDC3 → GAA (>>) |
| SDC3 → AMDHD2 (>>) |
| SDC3 → POU1F1 (>>) |
| SDC3 → CASC5 (>>) |
| SDC3 → SIM2 (>>) |
| SDC3 → GRM3 (>>) |
| SDC3 → SRPK2 (>>) |
| SDC3 → CEP152 (>>) |
| SDC3 → PMP2 (>>) |
| SDC3 → FAM55C (>>) |
| SDC3 → CT62 (>>) |
| SDC3 → MAPK12 (>>) |
| SDC3 → HPSE (>>) |
| SDC3 → PRKACA (>>) |
| SDC3 → NPIPL2 (>>) |
| SDC3 → RWDD2B (>>) |
| SDC3 → WDR91 (>>) |
| SDC3 → SEPT6 (>>) |
| SDC3 → TMEM111 (>>) |
